학술논문
182 - Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells
Document Type
Abstract
Author
Source
In Biology of Blood and Marrow Transplantation March 2018 24(3) Supplement:S171-S171
Subject
Language
ISSN
1083-8791